• iSIGN Media Solutions (ISD) has announced a non-brokered offering for gross proceeds of up to $575,000
  • iSIGN Media will issue up to 11.5 million units at a price of $0.05 per unit
  • iSIGN Media plans to use the funds for operations, software development, hardware acquisition and production
  • iSIGN is a data-focused, software-as-a-service (SaaS) company that is a pioneering leader in the areas of location-based security alert messaging and proximity marketing
  • iSign Media Solutions Inc. opened trading at $0.035 per share

iSIGN Media Solutions (ISD) has announced a non-brokered offering for aggregate gross proceeds of up to $575,000.

The company will issue up to 11.5 million units at $0.05 per unit. Each unit consists of one common share and one common share purchase warrant. Each warrant will entitle the holder to purchase one common share at a price of $0.125 for a period of 24 months.

iSIGN Media plans to use the funds for operations, software development, hardware acquisition and production. The company believes that this will bring specific opportunities to fruition that utilize iSIGN’s HALO and HALOfx platforms.

There are no fees associated with this placement.

All securities issued are subject to a statutory four-month hold period.

iSIGN is a data-focused, software-as-a-service (SaaS) company that is a pioneering leader in the areas of location-based security alert messaging and proximity marketing utilizing Bluetooth and Wi-Fi connectivity in complete privacy.

iSign Media Solutions Inc. opened trading at $0.035 per share.


More From The Market Online

Westinghouse Electric files for US IPO

Westinghouse Electric Company, jointly owned by Cameco and Brookfield Renewable Partners, confidentially filed for a US IPO.

The 5-Minute Investor Podcast, Ep. 72: The next AI gold rush is copper

Check out ep. 72 of The 5-Minute Investor Podcast, with analysis on copper stocks Freeport-McMoRan and Capstone Copper.

Buzz on the Bullboards: Contracts, cashflows, and delistings

Uncertainty around Iran has weighed on sentiment, reminding investors that even strong stories can be overshadowed by geopolitical risk.

EU authorizes new COVID vaccine from Pfizer and BioNTech

The EU grants marketing authorization to Pfizer and BioNTech's COVID-19 vaccine targeting the new XFG variant.